NCT06245616 · ACTIVE NOT RECRUITING
Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace Oil
This trial is testing whether olive pomace oil, compared to high-oleic sunflower oil, reduces inflammation in the hours after a meal in people with early-stage Alzheimer's. Researchers will draw blood at regular intervals over six hours to track inflammatory markers. It is a Phase NA study, meaning it is a controlled dietary experiment rather than a drug trial testing efficacy or safety at scale.
You may qualify if
- Clinical diagnosis of Alzheimer's disease.
- Adequate visual and hearing abilities.
- Able to consume breakfast without help.
You're excluded if
- Clinically significant psychiatric disorders.
- Systemic disease or infection that could affect safety.
- Cardiovascular disease within the last 2 years.
- Uncontrolled hypertension within the last 6 months.
- Cancer within the last 5 years.
- Drug or alcohol abuse within the last 2 years.
- Insulin-dependent diabetes.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-02-12